Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21291324rdf:typepubmed:Citationlld:pubmed
pubmed-article:21291324lifeskim:mentionsumls-concept:C0282554lld:lifeskim
pubmed-article:21291324lifeskim:mentionsumls-concept:C0040711lld:lifeskim
pubmed-article:21291324lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:21291324lifeskim:mentionsumls-concept:C0663246lld:lifeskim
pubmed-article:21291324lifeskim:mentionsumls-concept:C1150423lld:lifeskim
pubmed-article:21291324lifeskim:mentionsumls-concept:C1257757lld:lifeskim
pubmed-article:21291324lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:21291324pubmed:issue5lld:pubmed
pubmed-article:21291324pubmed:dateCreated2011-5-6lld:pubmed
pubmed-article:21291324pubmed:abstractTextInterleukin-1 receptor-associated kinase 2 (IRAK2) has been shown to be essential for lipopolysaccharide (LPS)-mediated posttranscriptional control of cytokine and chemokine production. In this study, we investigated the role of IRAK2 kinase activity in LPS-mediated posttranscriptional control by reconstituting IRAK2-deficient macrophages with either wild-type or kinase-inactive IRAK2. Compared with wild-type IRAK2 (IRAK2-WT) macrophages, kinase-inactive IRAK2 (IRAK2-KD) macrophages show reduced cytokine and chemokine mRNA stability and translation in response to LPS. Further, LPS-treated IRAK2-KD macrophages also show reduced activation of MKK3/6, MNK1, and eIF4E and attenuated toll-like receptor 4-induced tristetraprolin modification and stabilization. Taken together, these results suggest that the kinase activity of IRAK2 is required for the optimal activation of mitogen-activated protein kinase signaling, which regulates cytokine and chemokine production at posttranscriptional levels.lld:pubmed
pubmed-article:21291324pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:languageenglld:pubmed
pubmed-article:21291324pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:citationSubsetIMlld:pubmed
pubmed-article:21291324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21291324pubmed:statusMEDLINElld:pubmed
pubmed-article:21291324pubmed:monthMaylld:pubmed
pubmed-article:21291324pubmed:issn1557-7465lld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:XiaoHuiHlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:LiXiaoxiaXlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:ZhouHaoHlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:YinWeiguoWlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:FoxPaulPlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:YaoPengPlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:KimTae WhanTWlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:WanYouzhongYlld:pubmed
pubmed-article:21291324pubmed:authorpubmed-author:XiaoJianhuaJlld:pubmed
pubmed-article:21291324pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21291324pubmed:volume31lld:pubmed
pubmed-article:21291324pubmed:ownerNLMlld:pubmed
pubmed-article:21291324pubmed:authorsCompleteYlld:pubmed
pubmed-article:21291324pubmed:pagination415-22lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:meshHeadingpubmed-meshheading:21291324...lld:pubmed
pubmed-article:21291324pubmed:year2011lld:pubmed
pubmed-article:21291324pubmed:articleTitleThe kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation.lld:pubmed
pubmed-article:21291324pubmed:affiliationDepartment of Microbiology and Immunology, University of South China, Hengyang Hunan, China.lld:pubmed
pubmed-article:21291324pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21291324pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:108960entrezgene:pubmedpubmed-article:21291324lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21291324lld:entrezgene